Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KAPLAN JE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kaplan, JE; Sepkowitz, K; Masur, H; Sirisanthana, T; Russo, M; Chapman, L
      Opportunistic infections in persons with HIV or other immunocompromising conditions

      EMERGING INFECTIOUS DISEASES
    2. Dworkin, MS; Williamson, J; Jones, JL; Kaplan, JE
      Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious diseases

      CLINICAL INFECTIOUS DISEASES
    3. Dworkin, MS; Ward, JW; Hanson, DL; Jones, JL; Kaplan, JE
      Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination

      CLINICAL INFECTIOUS DISEASES
    4. Kaplan, JE; Hanson, DL; Jones, JL; Dworkin, MS
      Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents

      AIDS
    5. Dykewicz, CA; Jaffe, HW; Kaplan, JE
      Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients - Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    6. Cohn, DL; O'Brien, RJ; Geiter, LJ; Gordin, FM; Hershfield, E; Horsburgh, CR; Jereb, JA; Jordan, TJ; Kaplan, JE; Nolan, CM; Starke, JR; Taylor, Z; Villarino, ME; Binkin, NJ; Bock, NN; Castro, KG; Chaisson, RE; Comstock, RE; Dworkin, MS; El-Sadr, W; Fujiwara, PI; Glassroth, JC; Godfrey-Faussett, P; Goldberger, MJ; Hadler, JL; Hopewell, PC; Iseman, MD; Jacobs, RF; Land, MA; Lobato, MN; Menzies, RI; Migliori, GB; Miller, BI; Mwinga, A; Nardell, EA; Neaton, J; Qualls, NL; Reichman, LB; Rose, DN; Salpeter, SR; Sawert, H; Simone, PM; Snider, DE; Tsevat, J; Vernon, AA; Whalen, CC; Wilcosky, TC
      Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    7. Kaplan, JE; Jones, JL; Dykewicz, CA
      Protists as opportunistic pathogens: Public health impact in the 1990s andbeyond

      JOURNAL OF EUKARYOTIC MICROBIOLOGY
    8. Masur, H; Holmes, KK; Kaplan, JE
      Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

      CLINICAL INFECTIOUS DISEASES
    9. Kaplan, JE; Hanson, D; Dworkin, MS; Frederick, T; Bertolli, J; Lindegren, ML; Holmberg, S; Jones, JL
      Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    10. Kaplan, JE; Masur, H; Holmes, KK; Freedberg, KA; Holtgrave, D; Piscitelli, SC; Van Dyke, R; Watts, H
      An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons

      CLINICAL INFECTIOUS DISEASES
    11. Masur, H; Kaplan, JE; Holmes, KK; Alston, BL; Ampel, N; Anderson, JR; Baker, AC; Barr, D; Bartlett, JG; Bennett, JE; Benson, CA; Bozzette, SA; Chaisson, RE; Crumpacker, CS; Currier, JS; Deyton, L; Drew, WL; Duncan, WR; Eisinger, RW; El-Sadr, W; Feinberg, J; Freedberg, KA; Furrer, H; Gnann, JW; Goldberger, MJ; Goldie, S; Goosby, EP; Gross, PA; Hafner, R; Havlir, D; Hooton, TM; Jabs, DA; Jacobson, MA; Janoff, E; Kitahata, M; Kovacs, JV; Leport, C; Levin, MJ; Lopez, JC; Marco, M; Mayers, DL; Melnick, DA; Mofenson, LM; Montaner, JSG; Moore, R; Neaton, J; Nelson, C; O'Neill, JF; Palefsky, J; Pau, A; Phair, JP; Piscitelli, S; Polis, MA; Quinn, TC; Reiss, P; Rimland, D; Sears, CL; Seeff, L; Sepkowitz, KA; Slama, TG; Sloand, EM; Spector, SA; Thomas, DL; Van Dyke, RB; Watts, DH; Wheat, LJ; Whitcup, SM; Williams, P; Wright, TC; Castro, KG; DeCock, KM; Dowell, SF; Dworkin, MS; Dykewicz, C; Ellerbrock, T; Hajjeh, R; Holmberg, S; Holtgrave, DR; Jaffe, HW; Jones, JL; Juranek, DD; Mast, E; Navin, T; Pellett, PE; Reeves, WC; Stewart, JA; Villarino, ME
      1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

      CLINICAL INFECTIOUS DISEASES
    12. Chapman, LE; Green, TA; Ahmed, F; Parekh, BS; Rimland, D; Kaplan, JE; Thompson, MA; Folks, TM
      Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+T-lymphocyte counts of more than 500 x 10(6) cells/l

      AIDS
    13. Dworkin, MS; Hanson, DL; Kaplan, JE; Jones, JL; Ward, JW
      Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4(+) T lymphocyte counts above prophylaxis thresholds

      JOURNAL OF INFECTIOUS DISEASES
    14. Navin, TR; Rimland, D; Lennox, JL; Jernigan, J; Cetron, M; Hightower, A; Roberts, JM; Kaplan, JE
      Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus

      JOURNAL OF INFECTIOUS DISEASES
    15. Kaplan, JE; Parham, DL; Soto-Torres, L; van Dyck, K; Greaves, JA; Rauch, K; Ellis, B; Amandus, HE
      Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    16. Kaplan, JE; Janoff, EN; Masur, H
      Do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease? Editorial response

      CLINICAL INFECTIOUS DISEASES
    17. Maloney, EM; Armien, B; Gracia, F; Castillo, L; Kruger, H; Levin, A; Levine, PH; Kaplan, JE; Blattner, WA; Giusti, RM
      Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama

      JOURNAL OF INFECTIOUS DISEASES
    18. Jones, JL; Hanson, DL; Dworkin, MS; Alderton, DL; Fleming, PL; Kaplan, JE; Ward, J
      Surveillance for AIDS-defining opportunistic illnesses, 1992-1997

      ARCHIVES OF DERMATOLOGY
    19. Masur, H; Kaplan, JE; Holmes, KK; Alston, BL; Ampel, N; Anderson, JR; Baker, AC; Barr, D; Bartlett, JG; Bennett, JE; Benson, CA; Bozzette, SA; Chaisson, RE; Crumpacker, CS; Currier, JS; Deyton, L; Drew, WL; Duncan, WR; Eisinger, RW; El-Sadr, W; Feinberg, J; Freedberg, KA; Furrer, H; Gnann, JW; Goldberger, MJ; Goldie, S; Goosby, EP; Gross, PA; Hafner, R; Havlir, D; Hooton, TM; Jabs, DA; Jacobson, MA; Janoff, E; Kitahata, M; Kovacs, JV; Leport, C; Levin, MJ; Lopez, JC; Marco, M; Mayers, DL; Melnick, DA; Mofenson, LM; Montaner, JSG; Moore, R; Neaton, J; Nelson, C; O'Neill, JF; Palefsky, J; Pau, A; Phair, JP; Piscitelli, S; Polis, MA; Quinn, TC; Reiss, P; Rimland, D; Sears, CL; Seeff, L; Sepkowitz, KA; Slama, TG; Sloand, EM; Spector, SA; Thomas, DL; Van Dyke, RB; Watts, DH; Wheat, LJ; Whitcup, SM; Williams, P; Wright, TC; Castro, KG; DeCock, KM; Dowell, SF; Dworkin, MS; Dykewicz, C; Ellerbrock, T; Hajjeh, R; Holmberg, S; Holtgrave, DR; Jaffe, HW; Jones, JL; Juranek, DD; Mast, E; Navin, T; Pellett, PE; Reeves, WC; Stewart, JA; Villarino, ME; Kaplan, JE
      1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

      ANNALS OF INTERNAL MEDICINE
    20. PENC SF; BLUMENSTOCK FA; KAPLAN JE
      A 70-KDA AMINO-TERMINAL FIBRONECTIN FRAGMENT SUPPORTS GELATIN-BINDINGTO MACROPHAGES AND DECREASES GELATINASE ACTIVITY

      Journal of leukocyte biology
    21. KAPLAN JE; HANSON DL; NAVIN TR; JONES JL
      RISK-FACTORS FOR PRIMARY PNEUMOCYSTIS-CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADOLESCENTS AND ADULTS IN THE UNITED-STATES - REASSESSMENT OF INDICATIONS FOR CHEMOPROPHYLAXIS

      The Journal of infectious diseases
    22. JONES JL; HANSON DL; DWORKIN MS; KAPLAN JE; WARD JW
      TRENDS IN AIDS-RELATED OPPORTUNISTIC INFECTIONS AMONG MEN WHO HAVE SEX WITH MEN AND AMONG INJECTING DRUG-USERS, 1991-1996

      The Journal of infectious diseases
    23. KAPLAN JE; ROSELLE G; SEPKOWITZ K
      OPPORTUNISTIC INFECTIONS IN IMMUNODEFICIENT POPULATIONS

      EMERGING INFECTIOUS DISEASES
    24. MASUR H; KAPLAN JE; HOLMES KK; BAKER AC; BARR D; BENSON C; BROSGART C; CHAISSON R; COOPER E; CRUMPACKER C; DECKER C; DREW L; EISINGER R; ELSADR W; FREEDBERG K; GOLDBERGER M; GORDIN F; GREAVES W; GROSS P; HAFNER R; HAVLIR D; HORSBURGH R; JABS D; KITAHATA M; KOVACS J; MARTONE W; MAYERS D; MELNICK D; MOFENSON L; NEATON J; NELSON C; OLDFIELD E; PHAIR J; POLIS M; POLSKY B; POWDERLY W; RIMLAND D; SLOAND E; SOLOMON L; SPECTOR S; SPERLING R; TRAPNELL CB; VANDYKE R; WHITLEY R; WRIGHT T; BELAY E; BUTLER JC; CASTRO KG; DYKEWICZ C; EDLIN BR; ELLERBROCK T; HAJJEH RA; JAFFE HW; JURANEK D; MCNEIL M; MILLER B; PELLETT PE; REEVES W; SCHLUTER WW; SPIEGEL RA; STEWART JA; STYRT B; VERNON SD; WARD J
      PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/

      Clinical infectious diseases
    25. MASUR H; KAPLAN JE; HOLMES KK; ARMSTRONG D; BAKER AC; BARR D; BENSON C; BROSGART C; CHAISSON R; COOPER E; CRUMPACKER C; DECKER C; DREW L; EISINGER R; ELSADR W; FREEDBERG K; GOLDBERGER M; GORDIN F; GREAVES W; GROSS P; HAFNER R; HAVLIR D; HORSBURGH R; JABS D; KITAHATA M; KOVACS J; MARTONE W; MAYERS D; MELNICK D; MOFENSON L; NEATON J; NELSON C; OLDFIELD E; PHAIR J; POLIS M; POLSKY B; POWDERLY W; RIMLAND D; SLOAND E; SOLOMON L; SPECTOR S; SPERLING R; TRAPNELL CB; VANDYKE R; WHITLEY R; WRIGHT T; BELAY E; BUTLER JC; CASTRO KG; DYKEWICZ C; EDLIN BR; ELLERBROCK T; HAJJEH RA; JAFFE HW; JURANEK D; MCNEIL M; MILLER B; PELLETT PE; REEVES W; SCHLUTER WW; SPIEGEL RA; STEWART JA; STYRT B; VERNON SD; WARD J
      1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/

      Clinical infectious diseases
    26. PATIL S; KAPLAN JE; MINNEAR FL
      PROTEIN, NOT ADENOSINE OR ADENINE-NUCLEOTIDES, MEDIATES PLATELET DECREASE IN ENDOTHELIAL PERMEABILITY

      American journal of physiology. Heart and circulatory physiology
    27. KAPLAN JE; MASUR H; JAFFE HW; HOLMES KK
      PREVENTING OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HIV - 1997 GUIDELINES

      JAMA, the journal of the American Medical Association
    28. KAPLAN JE; JAFFE HW; MASUR H; HOLMES KK
      PREVENTING OPPORTUNISTIC INFECTIONS IN HIV-INFECTED INJECTION-DRUG USERS - REPLY

      JAMA, the journal of the American Medical Association
    29. KAPLAN JE; KHABBAZ RF; MURPHY EL; HERMANSEN S; ROBERTS C; LAL R; HENEINE W; WRIGHT D; MATIJAS L; THOMSON R; RUDOLPH D; SWITZER WM; KLEINMAN S; BUSCH M; SCHREIBER GB; WILLIAMS AE; NASS CC; OWNBY HE; SHAFER AW; KLEINMAN SH; HUTCHING S; BUSCH MP; GILCHER RO; SMITH JW; THOMSON RA; NEMO GJ; ZUCK TF
      MALE-TO-FEMALE TRANSMISSION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-IAND TYPE-II - ASSOCIATION WITH VIRAL LOAD

      Journal of acquired immune deficiency syndromes and human retrovirology
    30. KAPLAN JE; SPIRA TJ; FISHBEIN DB; LYNN HS
      14-YEAR FOLLOW-UP OF HIV-INFECTED HOMOSEXUAL MEN WITH LYMPHADENOPATHYSYNDROME

      Journal of acquired immune deficiency syndromes and human retrovirology
    31. CASTRO KG; BLINKHORN RJ; ELLNER JJ; CHAISSON RE; HORSBURGH CR; MASUR H; HOLMES KK; KAPLAN JE
      SECONDARY PROPHYLAXIS FOR TUBERCULOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - REPLY

      Clinical infectious diseases
    32. PATIL ST; KAPLAN JE; MINNEAR FL
      HEAT-RESISTANT FACTOR GREATER-THAN-3.5 KD MEDIATES THE PLATELET-INDUCED DECREASE IN ENDOTHELIAL PERMEABILITY IN-VITRO

      The FASEB journal
    33. DREVLOW BE; SCHILLING EM; KHABBAZ RF; KAPLAN JE; FUKUDA K; SINACORE J; RAMSEYGOLDMAN R
      RETROVIRAL RISK-FACTORS IN PATIENTS WITH AUTOIMMUNE-DISEASE

      Journal of rheumatology
    34. JONES JL; HANSON DL; CHU SY; CIESIELSKI CA; KAPLAN JE; WARD JW; NAVIN TR
      TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PERSONS - RISK-FACTORS AND TRENDS

      AIDS
    35. HENEINE W; SWITZER WM; BUSCH MP; KHABBAZ RF; KAPLAN JE; LAL RB
      ABSENCE OF PRIMATE T-LYMPHOTROPIC VIRUSES (PTLVS) IN HTLV-INDETERMINATE DONORS

      Transfusion
    36. HERSHOW RC; GALAI N; FUKUDA K; GRABER J; VLAHOV D; REZZA G; KLEIN RS; JARLAIS DCD; VITEK C; KHABBAZ R; FREELS S; ZUCKERMAN R; PEZZOTTI P; KAPLAN JE
      AN INTERNATIONAL COLLABORATIVE STUDY OF THE EFFECTS OF COINFECTION WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-II ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DISEASE PROGRESSION IN INJECTION-DRUG USERS

      The Journal of infectious diseases
    37. KAPLAN JE; HU DJ; HOLMES KK; JAFFE HW; MASUR H; DECOCK KM
      PREVENTING OPPORTUNISTIC INFECTIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS - IMPLICATIONS FOR THE DEVELOPING-WORLD

      The American journal of tropical medicine and hygiene
    38. VLAHOV D; KHABBAZ RF; COHN S; GALAI N; TAYLOR E; KAPLAN JE
      INCIDENCE AND RISK-FACTORS FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE-II SEROCONVERSION AMONG INJECTING DRUG-USERS IN BALTIMORE, MARYLAND, USA

      Journal of acquired immune deficiency syndromes and human retrovirology
    39. HENEINE W; MUSEY VC; SINHA SD; LANDAY A; NORTHRUP G; KHABBAZ R; KAPLAN JE
      ABSENCE OF EVIDENCE FOR HUMAN SPUMARETROVIRUS SEQUENCES IN PATIENTS WITH GRAVES-DISEASE

      Journal of acquired immune deficiency syndromes and human retrovirology
    40. HENEINE W; SWITZER WM; BUSCH M; KHABBAZ RF; KAPLAN JE; LAL RB
      THE SEARCH FOR HUMAN INFECTION WITH DIVERGENT PRIMATE T LYMPHOTROPIC VIRUSES

      Journal of acquired immune deficiency syndromes and human retrovirology
    41. KAPLAN JE; KHABBAZ RF; MURPHY EL; HERMANSEN S; ROBERTS C
      VIRAL LOAD IS ASSOCIATED WITH MALE-TO-FEMALE SEXUAL TRANSMISSION OF HTLV-I AND HTLV-II

      Journal of acquired immune deficiency syndromes and human retrovirology
    42. GRACIA F; CASTILLO LC; LARREATEGUI M; ROBERTS B; CEDENO V; HENEINE W; BLATTNER W; KAPLAN JE; LEVINE PH
      RELATION BETWEEN HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND NEUROLOGIC DISEASES IN PANAMA - 1985-1990

      Journal of acquired immune deficiency syndromes and human retrovirology
    43. SWITZER WM; BUSCH M; KHABBAZ RF; KAPLAN JE; HENEINE W
      MOLECULAR DIFFERENTIATION OF HTLV-II BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    44. KAPLAN JE; MASUR H; HOLMES KK; MCNEIL MM; SCHONBERGER LB; NAVIN TR; HANSON DL; GROSS PA; JAFFE HW; LANIER D; SCHRAM N; COOPER E; FREEDBERG KA; MAYER K; BLINKHORN R; ELLNER J; ANGULO F; BERKELMAN R; BREIMAN R; BRYAN R; BUEHLER J; CLADWELL B; CASTRO K; CHILDS JE; CHU S; CIESIELSKI C; DROTMAN DP; EDLIN B; ELLERBROCK T; FLEMING P; GEITER L; HAJJEH R; HANSON D; HOLMBERG S; HUGHES J; JAFFE H; JONES J; JURANEK D; KAPLAN JE; KELLER D; MARTONE W; MILLER B; NAVIN T; NESLUND V; OSTROFF S; PELLETT PE; PINNER R; REEF S; REEVES WC; REGNERY R; RICHARDS F; ROGERS M; SIMONDS RJ; SIMONE P; SMITH D; SOLOMON S; SPIEGEL R; STEWART J; SWERDLOW D; VERNON S; WARD J; NEAL J; SCHLECH W; WILFERT C; HORSBURGH R; MCGOWAN J; RIMLAND D; GOLDBERGER M; TRAPNELL CB; BARR D; TORRES G; STETLER H; GROSS P; ELSADAR W; COTTON D; GREAVES W; BARTLETT J; CHAISSON R; FEINBERG J; QUINN T; HORMAN J; MACDONALD K; WILSON M; SPERLING R; AVANDANO A; BAKER AC; KALICA A; KOVACS J; POLIS M; SCHNITTMAN S; NELSON C; PHAIR J; BENSON C; WOOD B; HUGHES W; LUFT B; HYSLOP N; WHITLEY R; AMPEL N; DREW WL; KOEHLER J; WOFSY C
      USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/

      Clinical infectious diseases
    45. KAPLAN JE; MASUR H; HOLMES KK; WILFERT CM; SPERLING R; BAKER SA; TRAPNELL CB; FREEDBERG KA; COTTON D; POWDERLY WG; JAFFE HW; LANIER D; SCHRAM N; COOPER E; MAYER K; BLINKHORN R; ELLNER J; ANGULO J; BERKELMAN R; BREIMAN R; BRYAN R; BEUHLER J; CALDWELL B; CASTRO K; CHILDS JE; CHU S; CIESIELSKI C; DROTMAN DP; EDLIN B; ELLERBROCK T; FLEMING P; GEITER L; HAJJEH R; HANSON D; HOLMBERG S; HUGHES J; JAFFE H; JONES J; JURANEK D; KELLER D; MARTONE W; MCNEIL MM; MILLER B; NAVIN T; NESLUND V; OSTROFF S; PELLETT PE; PINNER R; REEF S; REEVES WC; REGNERY R; RICHARDS F; ROGERS M; SCHONBERGER LB; SIMONDS RJ; SIMONE P; SMITH D; SOLOMON S; SPIEGEL R; STEWART J; SWERDLOW D; VERNON S; WARD J; NEAL J; SCHLECH W; WILFERT C; HORSBURGH R; MCGOWAN J; RIMLAND D; GOLDBERGER M; BARR D; TORRES G; STETLER H; GROSS P; ELSADR W; GREAVES W; BARTLETT J; CHAISON R; FEINBERG J; QUINN T; HORMAN J; MACDONALD K; WILSON M; AVANDANO A; BAKER AC; KALICA A; KOVACS J; POLIS M; SCHNITTMAN S; NELSON C; PHAIR J; BENSON C; WOOD B; HUGHES W; LUFT B; HYSLOP N; WHITLEY R; AMPEL N; DREW WL; KOEHLER J; WOFSY C
      USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW/

      Clinical infectious diseases
    46. KAPLAN JE; MASUR H; HOLMES KK; LANIER D; SCHRAM N; COOPER E; FREEDBERG KA; MAYER K; BLINKHORN R; ELLNER J; ANGULO F; BERKELMAN R; BREIMAN R; BRYAN R; BUEHLER J; CALDWELL B; CASTRO K; CHILDS JE; CHU S; CIESIELSKI C; DROTMAN DP; EDLIN B; ELLERBROCK T; FLEMING P; GEITER L; HAJJEH R; HANSON D; HOLMBERG S; HUGHES J; JAFFE H; JONES J; JURANEK D; KELLER D; MARTONE W; MCNEIL MM; MILLER B; NAVIN T; NESLUND V; OSTROFF S; PELLETT PE; PINNER R; REEF S; REEVES WC; REGNERY R; RICHARDS F; ROGERS M; SCHONBERGER LB; SIMONDS RJ; SIMONE P; SMITH D; SOLOMON S; SPIEGEL R; STEWART J; SWERDLOW D; VERNON S; WARD J; NEAL J; SCHLECH W; WILFERT C; HORSBURGH R; MCGOWAN J; RIMLAND D; GOLDBERGER M; TRAPNELL CB; BARR D; TORRES G; STETLER H; GROSS P; ELSADR W; COTTON D; GREAVES W; BARTLETT J; CHAISSON R; FEINBERG J; QUINN T; HORMAN J; MACDONALD K; WILSON M; SPERLING R; AVANDANO A; BAKER AC; KALICA A; KOVACS J; POLIS M; SCHNITTMAN S; NELSON C; PHAIR J; BENSON C; WOOD B; HUGHES W; LUFT B; HYSLOP N; WHITLEY R; AMPEL N; DREW WL; KOEHLER J; WOFSY C
      USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/

      Clinical infectious diseases
    47. PHAIR JP; GROSS PA; KAPLAN JE; MASUR H; HOLMES KK; WILFERT CM
      QUALITY STANDARDS FOR PREVENTING OPPORTUNISTIC INFECTIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS AND THEIR IMPLEMENTATION

      Clinical infectious diseases
    48. GROSS PA; PHAIR JP; KAPLAN JE; HOLMES KK; MASUR H
      QUALITY STANDARD FOR THE ENUMERATION OF CD4(-IMMUNODEFICIENCY-VIRUS()LYMPHOCYTES IN ADULTS AND ADOLESCENTS INFECTED WITH HUMAN)

      Clinical infectious diseases
    49. PHAIR JP; MASUR H; GROSS PA; HOLMES KK; KAPLAN JE
      QUALITY STANDARD FOR THE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN ADULTS AND ADOLESCENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    50. PHAIR JP; GROSS PA; KAPLAN JE; MASUR H; HOLMES KK; WILFERT CM; MARTONE WJ; CASTRO KG
      QUALITY STANDARD FOR THE IDENTIFICATION AND TREATMENT OF PERSONS COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND MYCOBACTERIUM-TUBERCULOSIS

      Clinical infectious diseases
    51. WILFERT CM; MASUR H; GROSS PA; KAPLAN JE; HOLMES KK; PHAIR JP; SIMONDS RJ
      QUALITY STANDARD FOR THE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN INFANTS AND CHILDREN BORN TO WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    52. WILFERT CM; GROSS PA; KAPLAN JE; HOLMES KK; MASUR H; PHAIR JP; SIMONDS RJ
      QUALITY STANDARD FOR THE ENUMERATION OF CD4(-IMMUNODEFICIENCY-VIRUS()LYMPHOCYTES IN INFANTS AND CHILDREN EXPOSED TO OR INFECTED WITH HUMAN)

      Clinical infectious diseases
    53. WILFERT CM; KAPLAN JE; GROSS PA; MASUR H; HOLMES KK; PHAIR JP
      QUALITY STANDARD FOR THE IMMUNIZATION OF INFANTS AND CHILDREN BORN TOWOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    54. GROSS PA; KAPLAN JE; PHAIR JP; MASUR H; WILFERT CM; HOLMES KK
      INDICATORS FOR ASSESSMENT OF COMPLIANCE WITH QUALITY STANDARDS FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    55. PATIL S; KAPLAN JE; MINNEAR FL
      PRELIMINARY CHARACTERIZATION OF A PLATELET-DERIVED FACTOR THAT DECREASES ENDOTHELIAL MONOLAYER PERMEABILITY

      The FASEB journal
    56. AN SS; MINNEAR FL; KAPLAN JE
      EFFECTS OF FIBRONECTIN ON ISOLATED HUMAN PLATELET MORPHOLOGICAL-CHANGES AND PROTEIN-TYROSINE KINASE-ACTIVITY

      The FASEB journal
    57. LERCHE NW; HENEINE W; KAPLAN JE; SPIRA T; YEE JL; KHABBAZ RF
      AN EXPANDED SEARCH FOR HUMAN INFECTION WITH SIMIAN TYPE-D RETROVIRUS

      AIDS research and human retroviruses
    58. WOODS TC; GRABER JM; HERSHOW RC; KHABBAZ RF; KAPLAN JE; HENEINE W
      INVESTIGATION OF PROVIRAL LOAD IN INDIVIDUALS INFECTED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-II

      AIDS research and human retroviruses
    59. PENC SF; BLUMENSTOCK FA; KAPLAN JE
      A ROLE FOR A 70-KDA AMINO-TERMINAL FIBRONECTIN FRAGMENT IN SUPPORTINGSOLUBLE GELATIN INTERACTIONS WITH RAT PERITONEAL-MACROPHAGES

      Journal of leukocyte biology
    60. KAPLAN JE; MASUR H; JAFFE HW; HOLMES KK
      REDUCING THE IMPACT OF OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION - NEW GUIDELINES

      JAMA, the journal of the American Medical Association
    61. HENEINE W; SWITZER WM; BUSCH M; KHABBAZ RF; KAPLAN JE
      MOLECULAR SUBTYPING OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-2 BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS

      Journal of clinical microbiology
    62. SWITZER WM; PIENIAZEK D; SWANSON P; SAMDAL HH; SORIANO V; KHABBAZ RF; KAPLAN JE; LAL RB; HENEINE W
      PHYLOGENETIC RELATIONSHIP AND GEOGRAPHIC-DISTRIBUTION OF MULTIPLE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II SUBTYPES

      Journal of virology
    63. VANDYKE RB; HENEINE W; PERRIN ME; RUDOLPH D; STARSZAK E; WOODS T; SWITZER WM; KAPLAN JE
      MOTHER-TO-CHILD TRANSMISSION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-II

      The Journal of pediatrics
    64. JONES JL; FLEMING PL; CIESIELSKI CA; HU DJ; KAPLAN JE; WARD JW
      COCCIDIOIDOMYCOSIS AMONG PERSONS WITH AIDS IN THE UNITED-STATES

      The Journal of infectious diseases
    65. VITEK CR; GRACIA FI; GIUSTI R; FUKUDA K; GREEN DB; CASTILLO LC; ARMIEN B; KHABBAZ RF; LEVINE PH; KAPLAN JE; BLATTNER WA
      EVIDENCE FOR SEXUAL AND MOTHER-TO-CHILD TRANSMISSION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-II AMONG GUAYMI INDIANS, PANAMA

      The Journal of infectious diseases
    66. ADDISS DG; ARROWOOD MJ; BARTLETT ME; COLLEY DG; JURANEK DD; KAPLAN JE; PERCIASEPE R; ELDER JR; REGLI SE; BERGER PS
      CDC, EPA ISSUE DRINKING-WATER GUIDANCE FOR PEOPLE WITH WEAKENED IMMUNE-SYSTEMS

      Journal of environmental health
    67. HINO S; KATAMINE S; MIYAMOTO T; DOI H; TSUJI Y; YAMABE T; KAPLAN JE; RUDOLPH DL; LAI RB
      ASSOCIATION BETWEEN MATERNAL ANTIBODIES TO THE EXTERNAL ENVELOPE GLYCOPROTEIN AND VERTICAL TRANSMISSION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I - MATERNAL ANTI-ENV ANTIBODIES CORRELATE WITH PROTECTION IN NON-BREAST-FED CHILDREN

      The Journal of clinical investigation
    68. HADLOCK KG; GOH CJ; BRADSHAW PA; PERKINS S; LO J; KAPLAN JE; KHABBAZ R; FOUNG SKH
      DELINEATION OF AN IMMUNODOMINANT AND HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV)-SPECIFIC EPITOPE WITHIN THE HTLV-I TRANSMEMBRANE GLYCOPROTEIN

      Blood
    69. JURANEK DD; ADDISS DG; BARTLETT ME; ARROWOOD MJ; COLLEY DG; KAPLAN JE; PERCIASEPE R; ELDER JR; REGLI SE; BERGER PS
      CRYPTOSPORIDIOSIS AND PUBLIC-HEALTH - WORKSHOP REPORT

      Journal - American Water Works Association
    70. KAPLAN JE; MASUR H; HOLMES KK
      USPHS AND IDSA COLLABORATE ON GUIDELINES TO PREVENT OPPORTUNISTIC INFECTIONS IN HIV-INFECTED PERSONS

      EMERGING INFECTIOUS DISEASES
    71. LOHSOMBOON P; YOUNG NL; WENIGER BG; ATIKIJ B; LIMPAKARNJANARAT K; KHABBAZ RMF; KAPLAN JE
      NONDETECTION OF HTLV-I II AND HIV-2 IN THAILAND, 1991-1992/

      Journal of acquired immune deficiency syndromes
    72. HENEINE W; CHAN WC; LUST JA; SINHA SD; ZAKI SR; KHABBAZ RF; KAPLAN JE
      HTLV-II INFECTION IS RARE IN PATIENTS WITH LARGE GRANULAR LYMPHOCYTE LEUKEMIA

      Journal of acquired immune deficiency syndromes
    73. KAPLAN JE; CAMARA T; HANNE T; GREEN D; KHABBAZ R; LEGUENNO B
      LOW-PREVALENCE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AMONG PATIENTS WITH TUBERCULOSIS IN SENEGAL

      Journal of acquired immune deficiency syndromes
    74. PENC SF; BLUMENSTOCK FA; KAPLAN JE
      70 KD AMINO-TERMINAL FIBRONECTIN FRAGMENT AND SOLUBLE GELATIN INDUCES70 KD MEDIATED I-125 GELATIN-BINDING BY RAT PERITONEAL-MACROPHAGES

      The FASEB journal
    75. RIOS M; KHABBAZ RF; KAPLAN JE; KESSLER D; HALL W; BIANCO C
      TRANSMISSION OF HTLV-II BY HTLV-I SCREENED BLOOD PRODUCTS

      AIDS research and human retroviruses
    76. HINO S; KATAMINE S; MIYAMOTO T; DOI H; TSUJI Y; YAMABE T; KAPLAN JE; RUDOLPH DL; LAL RB
      MATERNAL ANTI-HTLV-1 ENV ANTIBODY TITER AS A MARKER OF MOTHER-TO-CHILD TRANSMISSION - DIFFERENTIAL RISK IN BOTTLE-FED AND BREAST-FED CHILDREN

      AIDS research and human retroviruses
    77. HENEINE W; WOODS TC; CHIN WC; LUST J; DAWSON C; NICOLSON J; KHABBAZ RF; KAPLAN JE
      THE ROLE OF HTLV-II INFECTION IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA

      AIDS research and human retroviruses
    78. WOODS TC; GRABER JM; HERSHOW RC; KHABBAZ RF; KAPLAN JE; HENEINE W
      INVESTIGATION OF HTLV-II PROVIRAL LOAD IN 2 INFECTED-POPULATIONS

      AIDS research and human retroviruses
    79. KHABBAZ RF; KAPLAN JE; MATIJAS L; WRIGHT D; LAL R; RUDOLPH D; MURPHY E; KLEINMAN S; SCHREIBER G
      RISK-FACTORS FOR HTLV-I AND HTLV-II SEXUAL TRANSMISSION

      AIDS research and human retroviruses
    80. HANSEN GR; HARRIS NV; FIELDS J; THIEDE H; GREEN D; KHABBAZ RF; KAPLAN JE
      RISK-FACTORS AND PREVALENCE OF HTLV I II AMONG INJECTION-DRUG USERS IN KING COUNTY WASHINGTON, 1989-1991/

      AIDS research and human retroviruses
    81. SWITZER WM; PEINIAZEK D; LAL RB; KHABBAZ RF; KAPLAN JE; FOLKS TM; HENEINE W
      RFLP AND PHYLOGENETIC ANALYSIS OF THE LTR FROM HTLV-II-INFECTED INDIVIDUALS PROVIDE NEW INSIGHTS INTO THE EVOLUTION OF HTLV-II

      AIDS research and human retroviruses
    82. KLEINMAN SH; KAPLAN JE; KHABBAZ RF; CALABRO MA; THOMSON R; BUSCH M
      EVALUATION OF A P21E-SPIKED WESTERN-BLOT (IMMUNOBLOT) IN CONFIRMING HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I OR TYPE-II INFECTION IN VOLUNTEER BLOOD-DONORS

      Journal of clinical microbiology
    83. THIEDE H; HARRIS NV; MCGOUGH JP; ROBERTS B; KHABBAZ RF; KAPLAN JE
      PREVALENCE OF HTLV TYPE-I AND TYPE-II AMONG DRUG-USERS IN KING COUNTY, WASHINGTON

      Western journal of medicine
    84. MOON DG; MATAYOSHI BM; WESTON LK; MINNEAR FL; KAPLAN JE
      FIBRONECTIN INHIBITION OF PLATELET THROMBUS FORMATION IN AN IN-VIVO PORCINE MODEL OF VASCULAR INJURY

      Thrombosis research
    85. MOON DG; MATAYOSHI BM; WESTON LK; MINNEAR FL; KAPLAN JE
      FIBRONECTIN INHIBITION OF PLATELET THROMBUS FORMATION IN AN IN-VIVO PORCINE MODEL OF VASCULAR INJURY

      Thrombosis research
    86. KHABBAZ RF; KAPLAN JE; MATIFAS L; WRIGHT D; LAL R; RUDOLPH D; MURPHY E; KLEINMAN S; SCHREIBER G
      RISK-FACTORS FOR HTLV-I AND HTLV-II SEXUAL TRANSMISSION

      Transfusion
    87. RIOS M; KHABBAZ RF; KAPLAN JE; HALL WW; KESSLER D; BIANCO C
      TRANSMISSION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV) TYPE-II BY TRANSFUSION OF HTLV-I-SCREENED BLOOD PRODUCTS

      The Journal of infectious diseases
    88. BUSCH MP; LAYCOCK M; KLEINMAN SH; WAGES JW; CALABRO M; KAPLAN JE; KHABBAZ RF; HOLLINGSWORTH CG; NASS C; JACKSON CM; OWNBY H; HUTCHING S; MURPHY EL; GILCHER RO; SCHREIBER GB; THOMSON R; NEMO GJ; ZUCK T
      ACCURACY OF SUPPLEMENTARY SEROLOGIC TESTING FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II IN US BLOOD-DONORS

      Blood
    89. HJELLE B; KHABBAZ RF; CONWAY GA; NORTH C; GREEN D; KAPLAN JE
      PREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II IN AMERICAN-INDIAN POPULATIONS OF THE SOUTHWESTERN UNITED-STATES

      The American journal of tropical medicine and hygiene
    90. KAPLAN JE; KHABBAZ RF
      THE EPIDEMIOLOGY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II

      Reviews in medical virology
    91. KAPLAN JE
      BIOMEDICAL-RESEARCH TRAINING MUST REMAIN A PRIORITY

      Academic medicine
    92. BLYSTONE SD; KAPLAN JE
      THE ROLE OF FIBRONECTIN IN MACROPHAGE FIBRIN BINDING - A POTENTIAL MECHANISM FOR HIGH-AFFINITY, HIGH-CAPACITY CLEARANCE OF CIRCULATING FIBRIN

      Blood coagulation & fibrinolysis
    93. HENEINE W; LERCHE NW; WOODS T; SPIRA T; LIFF JM; ELEY W; YEE JL; KAPLAN JE; KHABBAZ RF
      THE SEARCH FOR HUMAN INFECTION WITH SIMIAN TYPE-D RETROVIRUSES

      Journal of acquired immune deficiency syndromes
    94. HENEINE W; WOODS T; GREEN D; GRACIA F; FUKUDA K; BLATTNER W; KAPLAN JE
      DETECTION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II (HTLV-II) IN THEBREAST-MILK OF HTLV-II INFECTED MOTHERS USING THE POLYMERASE CHAIN-REACTION

      Journal of acquired immune deficiency syndromes
    95. RIOS M; KHABBAZ RF; KAPLAN JE; KESSLER D; HALL W; BIANCO C
      TRANSMISSION OF HTLV-II BY HTLV-I SCREENED BLOOD PRODUCTS

      Transfusion
    96. KHABBAZ RF; FUKUDA K; KAPLAN JE
      GUIDELINES FOR COUNSELING HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)-INFECTED AND HTLV TYPE-II-INFECTED PERSONS

      Transfusion
    97. KAPLAN JE
      WRIT IN GUAYMI BLOOD

      Natural history
    98. PARDI D; SWITZER WM; HADLOCK KG; KAPLAN JE; LAL RB; FOLKS TM
      COMPLETE NUCLEOTIDE-SEQUENCE OF AN AMERINDIAN HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II (HTLV-II) ISOLATE - IDENTIFICATION OF A VARIANT HTLV-II SUBTYPE-B FROM A GUAYMI INDIAN

      Journal of virology
    99. PARDI D; KAPLAN JE; COLIGAN JE; FOLKS TM; LAL RB
      IDENTIFICATION AND CHARACTERIZATION OF AN EXTENDED TAX PROTEIN IN HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II SUBTYPE-B ISOLATES

      Journal of virology
    100. DREVLOW BE; GARRY EM; KHABBAZ RF; KAPLAN JE; FUKUDA K; RAMSEYGOLDMAN R
      RETROVIRAL RISK-FACTORS IN PATIENTS WITH AUTOIMMUNE-DISEASE

      Clinical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 03:31:04